Construction of nanozyme based with mixed valence manganese oxide loaded on defective metal-organic frameworks for sensitive detection of biomarker procalcitonin
Biosensors and Bioelectronics · 2025
DOI: 10.1016/j.bios.2025.117339 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biosensors and Bioelectronics, 2025. Verfasst von Suimin Deng und 7 weiteren Autor:innen. Beteiligte Einrichtung: Analytical and Testing Center of Beijing Normal University, Beijing, 100875, China. Hauptthemen laut MEDLINE: Oxides, Manganese Compounds, Biosensing Techniques, Metal-Organic Frameworks. Die Arbeit wurde bisher 33-mal zitiert (Crossref) und nennt 77 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Nanozymes possess the advantages of high stability, adjustable catalytic activity and simple preparation processes, which position them as a promising alternative to natural enzymes. In this work, an oxidase-like nanozyme has been prepared by loading mixed valence manganese oxides (MnxOy) on defective PCN-224 MOFs (dPCN). Dodecanoic acid was utilized to introduce abundant mesoporous defects into the dPCN, allowing manganese oxide to grow in situ on the surface and within the pores. The mixed valence state of manganese oxides endowed the MnxOy@dPCN nanozyme (MdP) with redox and catalytic properties, and the high oxidase-like catalytic performance of MdP for TMB substrate also originated from its favorable electrical conductivity and affinity to the substrate. The reactive oxygen species of the catalytic reaction were mainly singlet oxygen (1O2) and peroxyl radicals (·O2-). Without the existence of hydrogen peroxide (H2O2), the nanozyme can rapidly and efficiently oxidize TMB substrate into blue oxidation state, which has strong absorbance at 650 nm. An immunosensor for detecting biomarker procalcitonin (PCT) in human serum samples has been established based on the high catalytic property of MdP nanozyme. The immunoassay for PCT has satisfactory accuracy and repeatability, and its linear detection range can reach to be 0.05-100 ng mL-1 with a limit of detection (LOD) of 0.011 ng mL-1. The result affords a promising idea to construct oxidase-like nanozyme, and provides a method for sensitive determination of PCT in complex matrices.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Analytical and Testing Center of Beijing Normal University, Beijing, 100875, China.
- Analytical and Testing Center of Beijing Normal University, Beijing, 100875, China; Beijing Acad Sci & Technol, Inst Anal & Testing, Beijing Ctr Phys & Chem Anal, Beijing, 100089, China.
- Department of Laboratory Medicine, Hebei Yanda Lu Daopei Hospital, Langfang, China.
- Analytical and Testing Center of Beijing Normal University, Beijing, 100875, China. Electronic address: liuy@bnu.edu.cn.
- Analytical and Testing Center of Beijing Normal University, Beijing, 100875, China. Electronic address: xiemx@bnu.edu.cn.
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Deng, S., Hao, Y., Yang, L., Yu, T., Wang, X., Liu, H., Liu, Y., & Xie, M. (2025). Construction of nanozyme based with mixed valence manganese oxide loaded on defective metal-organic frameworks for sensitive detection of biomarker procalcitonin. Biosensors and Bioelectronics. https://doi.org/10.1016/j.bios.2025.117339
Vancouver
Deng S, Hao Y, Yang L, Yu T, Wang X, Liu H, et al. Construction of nanozyme based with mixed valence manganese oxide loaded on defective metal-organic frameworks for sensitive detection of biomarker procalcitonin. Biosensors and Bioelectronics. 2025. doi:10.1016/j.bios.2025.117339
BibTeX
@article{Deng2025,
author = {Deng, Suimin and Hao, Yun and Yang, Lina and Yu, Tongtong and Wang, Xiangfeng and Liu, Hailing and Liu, Yuan and Xie, Mengxia},
title = {Construction of nanozyme based with mixed valence manganese oxide loaded on defective metal-organic frameworks for sensitive detection of biomarker procalcitonin},
journal = {Biosensors and Bioelectronics},
year = {2025},
doi = {10.1016/j.bios.2025.117339}
}
EUVIMED